Inspirata Accelerates Its Growth as a Leading Provider of AI/NLP Technology in Oncology Informatics
December 19, 2022 08:00 ET
|
Inspirata, Inc.
Tampa, Florida, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Inspirata Inc. and FUJIFILM Corporation signed an asset purchase agreement for Fujifilm to acquire Inspirata’s Dynamyx® digital pathology...
Healthcare Technology Leader Laure Tessier-Delivuk Joins Inspirata as Vice President of Operations for Oncology Informatics
November 17, 2022 09:04 ET
|
Inspirata, Inc.
Tampa, Florida, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Oncology informatics company, Inspirata, is pleased to announce the recent addition of a new key member to the company’s leadership team. Effective...
Experienced Healthcare Leader Laurie Smith Joins Inspirata as Vice President of Product Strategy for Clinical Trial Matching
October 11, 2022 09:37 ET
|
Inspirata, Inc.
Tampa, Florida, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Oncology informatics company, Inspirata, is pleased to announce the recent addition of a new key member to the company’s leadership team. Effective...
Inspirata Unveils New Partnership at the Association of Pathology Chairs (APC) Annual Meeting 2022
July 18, 2022 09:00 ET
|
Inspirata, Inc.
Chicago, IL, July 18, 2022 (GLOBE NEWSWIRE) -- Digital pathology and cancer informatics provider Inspirata is proud to announce a new partnership with precision pathology company SpIntellx, further...
Inspirata Joins Advarra’s New API Partner Program as an Inaugural Member
May 18, 2022 09:00 ET
|
Inspirata, Inc.
Tampa, Florida, May 18, 2022 (GLOBE NEWSWIRE) -- Cancer informatics provider Inspirata announced today that it has become a member of the Advarra Partner Program. As an inaugural API Gold partner,...
Inspirata Receives Industry’s First FDA Clearance for Scanner Agnostic Digital Pathology Software
March 08, 2022 09:30 ET
|
Inspirata, Inc.
Tampa, Florida, March 08, 2022 (GLOBE NEWSWIRE) -- Digital pathology and cancer informatics provider Inspirata announced today that it has received U.S. Food and Drug Administration (FDA) clearance...
NHS Cancer Alliance Implements Inspirata AI to Improve Clinical Trial Access for South West Patients
February 10, 2022 02:59 ET
|
Inspirata, Inc.
Bristol, United Kingdom, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata and the Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance (SWAG)...
WVU Medicine Relies on Inspirata’s Dynamyx™ Digital Pathology Solution to Transform Pathology Services
January 18, 2022 16:00 ET
|
Inspirata, Inc.
Morgantown, WV / Tampa, FL, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Today, digital pathology and cancer informatics solution provider Inspirata is pleased to announce that its Dynamyx Digital Pathology...
Inspirata Releases Latest Software and New Partnerships at Pathology Visions 2021
October 18, 2021 11:00 ET
|
Inspirata, Inc.
Las Vegas, NV / Tampa, FL, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Digital pathology and cancer informatics provider Inspirata is proud to announce their latest software release. At Pathology Visions...
OSF HealthCare Selects Inspirata as Its Cancer Informatics Solution Provider
July 20, 2021 09:00 ET
|
Inspirata, Inc.
Tampa, Florida, July 20, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today a new partnership with the integrated health system OSF HealthCare. ...